首页 > 最新文献

Influenza and Other Respiratory Viruses最新文献

英文 中文
Improved Resolution of Influenza Vaccination Responses With High-Throughput Live Virus Microneutralisation 用高通量活病毒微量中和技术提高流感疫苗应答的分辨率
IF 4.2 4区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2025-08-14 DOI: 10.1111/irv.70140
Lorin Adams, Phoebe Stevenson-Leggett, Jia Le Lee, James Bazire, Giulia Dowgier, Agnieszka Hobbs, Chloë Roustan, Annabel Borg, Christine Carr, Silvia Innocentin, Louise M. C. Webb, Callie Smith, Philip Bawumia, Nicola Lewis, Nicola O'Reilly, Svend Kjaer, Michelle A. Linterman, Ruth Harvey, Mary Y. Wu, Edward J. Carr

Background

Influenza remains a significant threat to human and animal health. Assessing serological protection against influenza has relied upon haemagglutinin inhibition (HAI) assays, which are used to gauge existing immune landscapes, seasonal vaccine decisions and in systems vaccinology studies. HAI assays were first described in the 1940s. Here, we adapt our high-throughput live virus microneutralisation (LV-N) assay for SARS-CoV-2, benchmark against HAI assays, and report serological vaccine responsiveness in a cohort of older (> 65 yo) community dwelling adults.

Methods

Influenza-specific antibody responses were assessed in 73 individuals, before and after receipt of the adjuvanted 2021–22 Northern Hemisphere quadrivalent vaccine. We performed both HAI and LV-N assays against all four viruses represented in the vaccine [A/Cambodia/e0826360/2020 (H3N2), IVR-215 (A/Victoria/2570/2019-like) (H1N1)pdm09, B/Phuket/3073/2013 (B/Yamagata lineage), B/Washington/02/2019 (B/Victoria lineage)], using sera drawn before vaccination [range: d-82 to d-5], and days 7 [d6–10] and 181 [d156–200] after vaccination. We compared serological responses within each assay and between assays.

Results

Both the traditional HAI assay and our high-throughput live virus microneutralisation identified vaccine-induced boosts in antibody titres. We found population-level concordance between the two assays (Spearman's correlation coefficient range 0.49–0.88; all p ≤ 1.4 × 10−5). The improved granularity of microneutralisation was better able to estimate fold changes of responses and quantify the inhibitory effect of pre-existing antibody.

Conclusions

Our high-throughput method offers an alternative approach to assess influenza-specific serological responses with improved resolution, with the potential to improve the annual assessment of existing antibody landscapes, to improve new vaccine strain evaluation, and to offer a step-change in systems vaccinology, and a facet of laboratory-based pandemic preparedness.

流感仍然是对人类和动物健康的重大威胁。评估对流感的血清学保护依赖于血凝素抑制(HAI)测定,这种测定用于衡量现有的免疫格局、季节性疫苗决策和系统疫苗学研究。HAI测定法在20世纪40年代首次被描述。在这里,我们将我们的高通量活病毒微量中和(LV-N)试验用于SARS-CoV-2,作为与HAI试验的基准,并报告了一组老年(65岁)社区居住成年人的血清学疫苗反应性。方法对73例接种2021-22北半球四价佐剂疫苗前后的流感特异性抗体反应进行了评估。我们对疫苗中代表的所有四种病毒[A/Cambodia/e0826360/2020 (H3N2), IVR-215 (A/Victoria/2570/2019-like) (H1N1)pdm09, B/Phuket/3073/2013 (B/Yamagata谱系),B/Washington/02/2019 (B/Victoria谱系)]进行了HAI和lc - n检测,使用接种前[范围:d-82至d-5]和接种后第7天[d6-10]和第181天[d156-200]抽取的血清。我们比较了每次检测内和检测间的血清学反应。结果传统的HAI试验和我们的高通量活病毒微量中和试验均鉴定出疫苗诱导的抗体滴度增强。我们发现两种检测方法在人群水平上是一致的(Spearman相关系数范围为0.49-0.88;均p≤1.4 × 10−5)。改进的微中和粒度能够更好地估计反应的折叠变化,并量化预先存在的抗体的抑制效果。我们的高通量方法提供了一种评估流感特异性血清学反应的替代方法,具有更高的分辨率,有可能改善现有抗体图谱的年度评估,改进新疫苗株评估,并提供系统疫苗学的逐步改变,以及基于实验室的大流行防范的一个方面。
{"title":"Improved Resolution of Influenza Vaccination Responses With High-Throughput Live Virus Microneutralisation","authors":"Lorin Adams,&nbsp;Phoebe Stevenson-Leggett,&nbsp;Jia Le Lee,&nbsp;James Bazire,&nbsp;Giulia Dowgier,&nbsp;Agnieszka Hobbs,&nbsp;Chloë Roustan,&nbsp;Annabel Borg,&nbsp;Christine Carr,&nbsp;Silvia Innocentin,&nbsp;Louise M. C. Webb,&nbsp;Callie Smith,&nbsp;Philip Bawumia,&nbsp;Nicola Lewis,&nbsp;Nicola O'Reilly,&nbsp;Svend Kjaer,&nbsp;Michelle A. Linterman,&nbsp;Ruth Harvey,&nbsp;Mary Y. Wu,&nbsp;Edward J. Carr","doi":"10.1111/irv.70140","DOIUrl":"https://doi.org/10.1111/irv.70140","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Influenza remains a significant threat to human and animal health. Assessing serological protection against influenza has relied upon haemagglutinin inhibition (HAI) assays, which are used to gauge existing immune landscapes, seasonal vaccine decisions and in systems vaccinology studies. HAI assays were first described in the 1940s. Here, we adapt our high-throughput live virus microneutralisation (LV-N) assay for SARS-CoV-2, benchmark against HAI assays, and report serological vaccine responsiveness in a cohort of older (&gt; 65 yo) community dwelling adults.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Influenza-specific antibody responses were assessed in 73 individuals, before and after receipt of the adjuvanted 2021–22 Northern Hemisphere quadrivalent vaccine. We performed both HAI and LV-N assays against all four viruses represented in the vaccine [A/Cambodia/e0826360/2020 (H3N2), IVR-215 (A/Victoria/2570/2019-like) (H1N1)pdm09, B/Phuket/3073/2013 (B/Yamagata lineage), B/Washington/02/2019 (B/Victoria lineage)], using sera drawn before vaccination [range: d-82 to d-5], and days 7 [d6–10] and 181 [d156–200] after vaccination. We compared serological responses within each assay and between assays.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Both the traditional HAI assay and our high-throughput live virus microneutralisation identified vaccine-induced boosts in antibody titres. We found population-level concordance between the two assays (Spearman's correlation coefficient range 0.49–0.88; all <i>p</i> ≤ 1.4 × 10<sup>−5</sup>). The improved granularity of microneutralisation was better able to estimate fold changes of responses and quantify the inhibitory effect of pre-existing antibody.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Our high-throughput method offers an alternative approach to assess influenza-specific serological responses with improved resolution, with the potential to improve the annual assessment of existing antibody landscapes, to improve new vaccine strain evaluation, and to offer a step-change in systems vaccinology, and a facet of laboratory-based pandemic preparedness.</p>\u0000 </section>\u0000 </div>","PeriodicalId":13544,"journal":{"name":"Influenza and Other Respiratory Viruses","volume":"19 8","pages":""},"PeriodicalIF":4.2,"publicationDate":"2025-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/irv.70140","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144843666","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Characteristics of Adults With Non-Hospitalized Severe Respiratory Illness: Findings From a COVID-19 Vaccine Effectiveness Evaluation in Kenya, 2022–2023 非住院严重呼吸系统疾病成人的特征:2022-2023年肯尼亚COVID-19疫苗有效性评估结果
IF 4.2 4区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2025-08-06 DOI: 10.1111/irv.70145
Radhika Gharpure, Young M. Yoo, Bryan O. Nyawanda, Raphael O. Anyango, Brian O. Onyando, Sidney Ogolla, Billy Ogwel, Eric Osoro, Philip Ngere, Samuel Kadivane, Nzisa Liku, Eva Leidman, Gideon O. Emukule, Richard Omore, Kathryn E. Lafond

Studies suggest the burden of non-hospitalized severe respiratory illness might be substantial in Kenya. Using data from a Kenya COVID-19 vaccine effectiveness evaluation, we compared characteristics of patients aged ≥12 years who were hospitalized with severe respiratory illness to outpatients who were referred for hospitalization and declined (non-hospitalized). Symptom presentation and lung radiograph findings were similar among both groups, and patients in both were diagnosed with critical conditions, including acute respiratory distress syndrome (12% hospitalized; 4% non-hospitalized) and sepsis (10% both). Findings underscore the importance of including non-hospitalized severe illness when estimating the burden of disease for respiratory viruses.

研究表明,在肯尼亚,非住院严重呼吸系统疾病的负担可能很大。使用来自肯尼亚COVID-19疫苗有效性评估的数据,我们比较了年龄≥12岁因严重呼吸系统疾病住院的患者与转诊住院并拒绝住院(非住院)的门诊患者的特征。两组患者的症状表现和肺部x线检查结果相似,两组患者均被诊断为危重情况,包括急性呼吸窘迫综合征(12%住院;4%未住院)和败血症(两者均为10%)。研究结果强调了在估计呼吸道病毒疾病负担时包括非住院严重疾病的重要性。
{"title":"Characteristics of Adults With Non-Hospitalized Severe Respiratory Illness: Findings From a COVID-19 Vaccine Effectiveness Evaluation in Kenya, 2022–2023","authors":"Radhika Gharpure,&nbsp;Young M. Yoo,&nbsp;Bryan O. Nyawanda,&nbsp;Raphael O. Anyango,&nbsp;Brian O. Onyando,&nbsp;Sidney Ogolla,&nbsp;Billy Ogwel,&nbsp;Eric Osoro,&nbsp;Philip Ngere,&nbsp;Samuel Kadivane,&nbsp;Nzisa Liku,&nbsp;Eva Leidman,&nbsp;Gideon O. Emukule,&nbsp;Richard Omore,&nbsp;Kathryn E. Lafond","doi":"10.1111/irv.70145","DOIUrl":"https://doi.org/10.1111/irv.70145","url":null,"abstract":"<p>Studies suggest the burden of non-hospitalized severe respiratory illness might be substantial in Kenya. Using data from a Kenya COVID-19 vaccine effectiveness evaluation, we compared characteristics of patients aged ≥12 years who were hospitalized with severe respiratory illness to outpatients who were referred for hospitalization and declined (non-hospitalized). Symptom presentation and lung radiograph findings were similar among both groups, and patients in both were diagnosed with critical conditions, including acute respiratory distress syndrome (12% hospitalized; 4% non-hospitalized) and sepsis (10% both). Findings underscore the importance of including non-hospitalized severe illness when estimating the burden of disease for respiratory viruses.</p>","PeriodicalId":13544,"journal":{"name":"Influenza and Other Respiratory Viruses","volume":"19 8","pages":""},"PeriodicalIF":4.2,"publicationDate":"2025-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/irv.70145","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144782771","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development of a Rapid Isothermal Assay for Detection of Adenovirus Types Important in Respiratory Infections 用于检测呼吸道感染中重要腺病毒类型的快速等温检测方法的建立
IF 4.2 4区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2025-08-02 DOI: 10.1111/irv.70142
Benedikt Beilstein, Iris Bachmann, Martin Spiegel, Frank T. Hufert, Gregory Dame

Background

Nucleic acid amplification tests (NAATs) for human adenoviruses (HAdVs) causing respiratory infections usually target the hexon gene. However, new HAdV types with substantial variations in the hexon gene may not be detected. Thus, we focus on NAATs based on a conserved region in the penton gene to detect all HAdV types causing respiratory infections.

Methods

A highly conserved region at the 3′ end of the penton gene was chosen as a target for NAAT. Primers and probes for quantitative polymerase chain reaction (qPCR) and isothermal recombinase polymerase amplification (RPA) were designed for the detection of all HAdV types causing respiratory infections.

Results

Two highly sensitive qPCR assays were established, one for the detection of HAdV-E4 and HAdV-B types and another for the detection of HAdV-C types (LOD < 10 standard DNA copies for both assays). Furthermore, a one-tube RPA with a universal RPA probe was developed for rapid detection of all HAdV types causing respiratory infections (LOD ≤ 244 standard DNA copies). All three assays were used for testing clinical nasopharyngeal swabs obtained from SARS-CoV-2-negative children with respiratory disease symptoms. Eight out of 243 samples tested were found to be HAdV positive by qPCR and by one-tube RPA, except for one sample with a very low viral load of 30 genome equivalents.

Conclusions

Penton gene-based NAAT systems were developed and successfully used for the detection of HAdV in clinical samples. The newly developed one-tube RPA assay offers the possibility for rapid and simple detection of respiratory HAdV infections at the point of need.

背景:用于检测引起呼吸道感染的人腺病毒(HAdVs)的核酸扩增试验(NAATs)通常针对六邻体基因。然而,具有六邻体基因显著变异的新型hav可能无法检测到。因此,我们将重点放在基于penton基因保守区域的naat上,以检测所有引起呼吸道感染的hav类型。方法选择penton基因3 '端的高度保守区域作为NAAT的靶点。设计了定量聚合酶链反应(qPCR)和等温重组酶扩增(RPA)的引物和探针,用于检测所有类型的hav引起呼吸道感染。结果建立了两种高灵敏度的qPCR检测方法,一种用于检测HAdV-E4和HAdV-B型,另一种用于检测HAdV-C型(两种检测方法的LOD <; 10个标准DNA拷贝)。此外,开发了一种带有通用RPA探针的单管RPA,用于快速检测所有引起呼吸道感染的hav类型(LOD≤244个标准DNA拷贝)。所有三项检测均用于检测从sars - cov -2阴性且有呼吸道疾病症状的儿童获得的临床鼻咽拭子。通过qPCR和单管RPA检测,243个样本中有8个发现hav阳性,除了一个样本的病毒载量非常低,只有30个基因组当量。结论建立了基于Penton基因的NAAT系统,并成功用于临床样品中hav的检测。新开发的单管RPA试验提供了在需要时快速和简单地检测呼吸道hav感染的可能性。
{"title":"Development of a Rapid Isothermal Assay for Detection of Adenovirus Types Important in Respiratory Infections","authors":"Benedikt Beilstein,&nbsp;Iris Bachmann,&nbsp;Martin Spiegel,&nbsp;Frank T. Hufert,&nbsp;Gregory Dame","doi":"10.1111/irv.70142","DOIUrl":"https://doi.org/10.1111/irv.70142","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Nucleic acid amplification tests (NAATs) for human adenoviruses (HAdVs) causing respiratory infections usually target the hexon gene. However, new HAdV types with substantial variations in the hexon gene may not be detected. Thus, we focus on NAATs based on a conserved region in the penton gene to detect all HAdV types causing respiratory infections.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>A highly conserved region at the 3′ end of the penton gene was chosen as a target for NAAT. Primers and probes for quantitative polymerase chain reaction (qPCR) and isothermal recombinase polymerase amplification (RPA) were designed for the detection of all HAdV types causing respiratory infections.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Two highly sensitive qPCR assays were established, one for the detection of HAdV-E4 and HAdV-B types and another for the detection of HAdV-C types (LOD &lt; 10 standard DNA copies for both assays). Furthermore, a one-tube RPA with a universal RPA probe was developed for rapid detection of all HAdV types causing respiratory infections (LOD ≤ 244 standard DNA copies). All three assays were used for testing clinical nasopharyngeal swabs obtained from SARS-CoV-2-negative children with respiratory disease symptoms. Eight out of 243 samples tested were found to be HAdV positive by qPCR and by one-tube RPA, except for one sample with a very low viral load of 30 genome equivalents.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Penton gene-based NAAT systems were developed and successfully used for the detection of HAdV in clinical samples. The newly developed one-tube RPA assay offers the possibility for rapid and simple detection of respiratory HAdV infections at the point of need.</p>\u0000 </section>\u0000 </div>","PeriodicalId":13544,"journal":{"name":"Influenza and Other Respiratory Viruses","volume":"19 8","pages":""},"PeriodicalIF":4.2,"publicationDate":"2025-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/irv.70142","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144758493","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surveillance of International Travel of COVID-19 Cases (SuITCases) in England 英国COVID-19病例(箱)国际旅行监测
IF 4.2 4区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2025-07-30 DOI: 10.1111/irv.70141
Mary A. Sinnathamby, Katherine Twohig, Nurin Abdul Aziz, Florence Halford, Asad Zaidi, Katie Harman, Simon Thelwall, Alex Allen, Gavin Dabrera

Introduction

The emergence of SARS-CoV-2 variants necessitated identification of travel-associated COVID-19 cases in England.

Methods

We implemented a novel integrated COVID-19-episode-level travel surveillance system, Surveillance of International COVID-19 Cases (SuITCases), to assign imported, sporadic or unknown travel status to COVID-19 cases, using data linkage between two enhanced and two routine data sources.

Results

SuITCases identified 517,988 travel-associated SARS-CoV-2 episodes (3.0% of total), where the two enhanced systems assigned most travel statuses.

Conclusions

Our unique system facilitated rapid identification of travel-associated COVID-19 cases, reducing transmission and informing public health actions. Enhanced surveillance data sources should be considered as potential tools for future outbreak investigations and pandemic preparedness.

随着SARS-CoV-2变体的出现,英国有必要确定与旅行相关的COVID-19病例。方法利用两个增强数据源和两个常规数据源之间的数据链接,实施了一种新型的COVID-19事件级综合旅行监测系统“国际COVID-19病例监测(手提箱)”,对COVID-19病例进行输入、散发或未知旅行状态的分配。结果手提箱确定了517,988例与旅行相关的SARS-CoV-2发作(占总数的3.0%),其中两个增强系统分配了大多数旅行状态。我们独特的系统有助于快速识别与旅行相关的COVID-19病例,减少传播并为公共卫生行动提供信息。应考虑将加强监测数据源作为未来疫情调查和大流行防范的潜在工具。
{"title":"Surveillance of International Travel of COVID-19 Cases (SuITCases) in England","authors":"Mary A. Sinnathamby,&nbsp;Katherine Twohig,&nbsp;Nurin Abdul Aziz,&nbsp;Florence Halford,&nbsp;Asad Zaidi,&nbsp;Katie Harman,&nbsp;Simon Thelwall,&nbsp;Alex Allen,&nbsp;Gavin Dabrera","doi":"10.1111/irv.70141","DOIUrl":"https://doi.org/10.1111/irv.70141","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>The emergence of SARS-CoV-2 variants necessitated identification of travel-associated COVID-19 cases in England.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We implemented a novel integrated COVID-19-episode-level travel surveillance system, Surveillance of International COVID-19 Cases (SuITCases), to assign imported, sporadic or unknown travel status to COVID-19 cases, using data linkage between two enhanced and two routine data sources.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>SuITCases identified 517,988 travel-associated SARS-CoV-2 episodes (3.0% of total), where the two enhanced systems assigned most travel statuses.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Our unique system facilitated rapid identification of travel-associated COVID-19 cases, reducing transmission and informing public health actions. Enhanced surveillance data sources should be considered as potential tools for future outbreak investigations and pandemic preparedness.</p>\u0000 </section>\u0000 </div>","PeriodicalId":13544,"journal":{"name":"Influenza and Other Respiratory Viruses","volume":"19 8","pages":""},"PeriodicalIF":4.2,"publicationDate":"2025-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/irv.70141","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144725419","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
No Evidence of Novel Respiratory Viruses on Two Texas Dairy Farms Before the H5N1 Avian Influenza Virus Epizootic 在H5N1禽流感病毒流行之前,没有证据表明德克萨斯州的两个奶牛场存在新型呼吸道病毒
IF 4.2 4区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2025-07-30 DOI: 10.1111/irv.70146
Laura A. Pulscher, Lyudmyla V. Maruschak, Ismaila Shittu, Hisham Alsharif, Gregory C. Gray

Livestock intensification and modern farming practices, such as confinement and increased livestock densities, are thought to be strongly linked to zoonotic disease emergence and amplification [1, 2]. This may favor increased transmission, particularly to those working in close contact with livestock [1]. The recent introduction and spread of H5N1 avian influenza virus into dairy farms and dairy farm workers in early 2024 [3] highlights a need for surveillance of emerging zoonotic respiratory diseases at the cattle worker–cattle interface. In addition to influenza A viruses (IAV), influenza D virus [4] (IDV) and bovine coronaviruses [5] (BCoVs) are reservoired in cattle and may spill over into other animals, including sometimes to humans. For example, recent molecular and serological evidence suggests IDV may be spilling over into humans, specifically those with close contact to cattle [6-8]. Similarly, BCoVs have a large host range, and most notably, the seasonal human coronavirus, OC43-CoV, is thought to have originated from cattle, sharing a 96% global nucleotide identity with BCoV [9]. To this end, this one health-oriented study sought to determine IAV, IDV, and coronavirus transmission on dairy farms. We did so by prospectively collecting samples from cattle workers, their cattle, and the dairy farm environment to better understand the epidemiology and ecology of IAV, IDV, and coronaviruses.

From December 2022 to December 2023, we prospectively collected samples from 53 dairy workers, 60 dairy cows, 30 bioaerosol samples, and 22 dust samples from farm environments on two dairy operations in Texas. With farm owners' approval, dairy farms were visited every 3–4 months over the course of the study. After obtaining signed consent, nasal washes were collected from cattle workers by injecting 5 mL of sterile water into one nostril and collecting the expressed fluid. Participants also permitted the collection of up to 10 mL of whole blood. Within 12 h of collection, blood was spun down, and sera aliquoted and placed on ice. Nasal swabs were also collected from five cows at each encounter and up to three cows each month in-between encounters, prioritizing cows with signs of respiratory illness. Briefly, animal technicians on farms placed 6-in. polyester swabs into the nare of a cow and then placed the swab into 3 mL of viral transport media (Huachenyang [Shenzhen] Technology Co. Ltd. or Rocky Mountain Biologicals LLC) samples were placed on ice or shipped on cold packs to UTMB for analysis.

Environmental sampling, including bioaerosol and dust sampling, was also conducted at each farm encounter. National Institute for Occupational Safety and Health (NIOSH) BC251 multi-stage bioaerosol samplers were placed in four locations on each farm where humans and cows were in close contact or where sick cows were located. Samplers were placed

畜牧业集约化和现代农业实践,如禁闭和牲畜密度增加,被认为与人畜共患疾病的出现和扩大密切相关[1,2]。这可能会增加传播,特别是对那些与牲畜密切接触的工作人员。最近H5N1禽流感病毒于2024年初在奶牛场和奶牛场工人中传入和传播,突出表明需要在牛工人-牛界面监测新出现的人畜共患呼吸道疾病。除了甲型流感病毒(IAV)外,D型流感病毒[4](IDV)和牛冠状病毒[5](bcov)也储存在牛体内,并可能蔓延到其他动物,有时包括人类。例如,最近的分子和血清学证据表明,IDV可能会传播给人类,特别是那些与牛有密切接触的人[6-8]。同样,BCoV具有很大的宿主范围,最值得注意的是,季节性人类冠状病毒OC43-CoV被认为起源于牛,与BCoV[9]具有96%的全球核苷酸同源性。为此,这项以健康为导向的研究试图确定IAV、IDV和冠状病毒在奶牛场的传播。为了更好地了解IAV、IDV和冠状病毒的流行病学和生态学,我们前瞻性地收集了牛工人、他们的牛和奶牛场环境的样本。从2022年12月到2023年12月,我们前瞻性地收集了德克萨斯州两个奶牛场农场环境中的53名奶牛场工人、60头奶牛、30个生物气溶胶样本和22个粉尘样本。在农场主人的同意下,研究人员在研究过程中每3-4个月访问一次奶牛场。在获得签署同意后,通过向牛工人的一个鼻孔注射5 mL无菌水并收集表达的液体来收集牛工人的鼻洗液。参与者还被允许采集多达10毫升的全血。在采集的12小时内,血液被纺下来,血清被提取并放置在冰上。每次接触时还从5头奶牛身上收集鼻拭子,在两次接触之间每月最多收集3头奶牛的鼻拭子,优先考虑有呼吸道疾病迹象的奶牛。简而言之,农场的动物技术人员将6英寸。将聚酯棉签插入奶牛的胸部,然后将棉签放入3 mL病毒运输培养基(华晨阳[深圳]科技有限公司或洛基山生物制品有限公司)中,将样品放在冰上或用冷袋运送到UTMB进行分析。环境采样,包括生物气溶胶和粉尘采样,也在每个农场进行。国家职业安全与健康研究所(NIOSH) BC251多级生物气溶胶采样器放置在每个农场的四个地点,这些地点是人与奶牛密切接触或病牛所在的地方。采样器尽可能放置在呼吸高度的中心位置,以3.5 L/min的流速运行3-4小时,并按照前面描述的[10]进行处理。液体气旋生物气溶胶收集器(Midwest Micro-Tek, Brookings, SD, USA)的流速为400 L/min,也被放置在挤奶室。最低必需介质(MEM) 10毫升;Gibco, Billings, MT)放入收集器中,运行30分钟,然后取出MEM并立即放置在冰上。使用8 × 8 Nalgene Super - dry Surface Protector湿纸巾(Thermo Scientific Nalgene)擦拭NIOSH空气采样器1米范围内约1平方英尺的不同硬表面(墙壁、栏杆、管道),收集粉尘样本。用抹布在每个袋子中加入20毫升PBS,用手混合2-3分钟,然后将PBS从抹布上挤出,放在冰上保存。所有样品在冰上保存,并在72小时内运送到UTMB一卫生实验室进行处理,并在- 20°C(血清)或- 80°C(所有其他样品)下保存,直至进一步分析。人类和动物取样的伦理监督由UTMB提供(IRB协议#22-0181和IACUC协议# TEMP-0523)。按照制造商的说明,使用QIAamp病毒RNA迷你试剂盒手工或QIACube Connect (Qiagen, Valencia, CA, USA)进行病毒RNA提取。然后使用AgPath-ID一步RT-PCR试剂(Applied Biosystems, Waltman, MA)对IAV[11](人和牛样本)的基质基因和IDV(所有样本)的NP[12]和PB1[13]基因进行实时RT-PCR (qRT-PCR)筛选。利用Superscript III Platinum One-Step RT-PCR系统,结合Platinum Taq DNA聚合酶(Thermo Fisher Scientific Inc., Waltham, MA)和Platinum Taq DNA聚合酶(Invitrogen),对冠状病毒[14]进行了靶向RNA依赖性RNA聚合酶(RdRp)基因组的凝胶型常规半巢式RT-PCR。扩增子被送去测序,并使用国家生物技术中心基本局部比对搜索工具(NCBI BLAST)评估序列与其他病毒的相似性。 使用重组H5N1病毒(Rg-A/秃鹰/佛罗里达/W22-134-OP/2022 PR8-H5N1),对受体破坏酶II (Denka Seiken,东京,日本)预处理的人血清样本进行微量中和试验(MN)。同样,使用流感D堪萨斯菌株(D/Bovine/Kansas/1-35/2010)进行IDV抗体的MN检测,如上所述[7]。在检测的89个样本中,3名养牛工人(3.4%)在鼻洗液中发现了冠状病毒的分子证据。NCBI BLAST分析显示,这三个序列与SARS-CoV-2/human/VNM/T1HN/2022 (NCBI登录号ON365836.1)具有密切的同源性(表1)。其他样本未发现IAV、IDV或cov的证据(表1)。在一次农场访问期间,在三名养牛工人中发现了SARS-CoV-2的分子证据,这可能表明当时该农场发生了小规模的SARS-CoV-2爆发。尽管我们在一年的时间里研究了奶牛场,但我们没有在收集的样本中检测到IAV, IDV和其他冠状病毒。考虑到H5N1禽流感病毒可能发生在2024年3月,因此我们在2022年12月至2023年12月取样的人或奶牛中未检测到禽流感病毒并不奇怪。尽管先前的研究报告了美国牛群中IDV[5]的患病率为2.4%-18%,bcov[5]的发病率为15.0%-70.0%,但我们没有在我们的奶牛样本中检测到IDV或bcov。有可能这些病毒没有在这些种群中传播,这些病毒在这些农场中的流行率很低,或者没有在牛中感染,因为大多数取样的牛是成年牛,IDV和bcov的最高感染率往往发生在1岁以下的小牛中[5,16]。同样,在本研究取样的牛工人中没有发现IDV或新型冠状病毒的证据,这可能是由于在同一时间取样的牛中没有这些病原体,或者这些病原体的流行率很低。未来的研究应集中在牛-牛工人的界面上,以充分了解新出现的人畜共患病毒蔓延到人类的威胁。Laura A. Pulscher:概念化,调查,写作-原始草案,方法论,验证,可视化,写作-审查和编辑,正式分析,项目管理。Lyudmyla V. Maruschak:调查,验证,可视化,写作-审查和编辑,方法论。Ismaila Shittu:方法论,验证,调查,写作-审查和编辑。希沙姆·阿尔沙里夫:方法论,调查,写作-审查和编辑。格雷戈里·c·格雷:概念化、方法论、调查、形式分析、监督、资金获取、可视化、项目管理、资源、写作-审查和编辑。作者声明他们没有利益冲突。
{"title":"No Evidence of Novel Respiratory Viruses on Two Texas Dairy Farms Before the H5N1 Avian Influenza Virus Epizootic","authors":"Laura A. Pulscher,&nbsp;Lyudmyla V. Maruschak,&nbsp;Ismaila Shittu,&nbsp;Hisham Alsharif,&nbsp;Gregory C. Gray","doi":"10.1111/irv.70146","DOIUrl":"https://doi.org/10.1111/irv.70146","url":null,"abstract":"<p>Livestock intensification and modern farming practices, such as confinement and increased livestock densities, are thought to be strongly linked to zoonotic disease emergence and amplification [<span>1, 2</span>]. This may favor increased transmission, particularly to those working in close contact with livestock [<span>1</span>]. The recent introduction and spread of H5N1 avian influenza virus into dairy farms and dairy farm workers in early 2024 [<span>3</span>] highlights a need for surveillance of emerging zoonotic respiratory diseases at the cattle worker–cattle interface. In addition to influenza A viruses (IAV), influenza D virus [<span>4</span>] (IDV) and bovine coronaviruses [<span>5</span>] (BCoVs) are reservoired in cattle and may spill over into other animals, including sometimes to humans. For example, recent molecular and serological evidence suggests IDV may be spilling over into humans, specifically those with close contact to cattle [<span>6-8</span>]. Similarly, BCoVs have a large host range, and most notably, the seasonal human coronavirus, OC43-CoV, is thought to have originated from cattle, sharing a 96% global nucleotide identity with BCoV [<span>9</span>]. To this end, this one health-oriented study sought to determine IAV, IDV, and coronavirus transmission on dairy farms. We did so by prospectively collecting samples from cattle workers, their cattle, and the dairy farm environment to better understand the epidemiology and ecology of IAV, IDV, and coronaviruses.</p><p>From December 2022 to December 2023, we prospectively collected samples from 53 dairy workers, 60 dairy cows, 30 bioaerosol samples, and 22 dust samples from farm environments on two dairy operations in Texas. With farm owners' approval, dairy farms were visited every 3–4 months over the course of the study. After obtaining signed consent, nasal washes were collected from cattle workers by injecting 5 mL of sterile water into one nostril and collecting the expressed fluid. Participants also permitted the collection of up to 10 mL of whole blood. Within 12 h of collection, blood was spun down, and sera aliquoted and placed on ice. Nasal swabs were also collected from five cows at each encounter and up to three cows each month in-between encounters, prioritizing cows with signs of respiratory illness. Briefly, animal technicians on farms placed 6-in. polyester swabs into the nare of a cow and then placed the swab into 3 mL of viral transport media (Huachenyang [Shenzhen] Technology Co. Ltd. or Rocky Mountain Biologicals LLC) samples were placed on ice or shipped on cold packs to UTMB for analysis.</p><p>Environmental sampling, including bioaerosol and dust sampling, was also conducted at each farm encounter. National Institute for Occupational Safety and Health (NIOSH) <span>BC</span>251 multi-stage bioaerosol samplers were placed in four locations on each farm where humans and cows were in close contact or where sick cows were located. Samplers were placed ","PeriodicalId":13544,"journal":{"name":"Influenza and Other Respiratory Viruses","volume":"19 8","pages":""},"PeriodicalIF":4.2,"publicationDate":"2025-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/irv.70146","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144740254","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Framework for Evaluating the Use of Surveillance Systems for Short-Term Influenza Forecasting 评估监测系统短期流感预报使用的框架
IF 4.2 4区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2025-07-29 DOI: 10.1111/irv.70144
Negin Maroufi, Lucy Telfar Barnard, Qiu Sue Huang, Gillian Dobbie, Nayyereh Aminisani, Steffen Albrecht, Nhung Nghiem, Michael G. Baker

Background

Public health surveillance systems need to monitor influenza activity and guide measures to mitigate its high impact on morbidity, mortality and healthcare systems. There is an increasing expectation that surveillance data will support the modeling of future short-term disease scenarios using artificial intelligence (AI) and machine learning (ML). This study examines how influenza surveillance can support AI/ML-based short-term forecasting for influenza at the community and hospital levels in a high-income country setting (Aotearoa/New Zealand).

Methods

This study used a two-phase approach. The first phase involved a comprehensive review of government reports, official websites, and literature to characterize existing influenza surveillance systems. The second phase evaluated systems against eight key attributes—timeliness, sensitivity, specificity, representativeness, coverage, robustness, completeness, and historical data—using a five-level ranking system. Attribute selection was informed by experts' knowledge, ML requirements, and established frameworks. Weighted scores for training and short-term forecasting capabilities were calculated to determine alignment with AI/ML requirements.

Results

The Southern Hemisphere Influenza and Vaccine Effectiveness Research and Surveillance (SHIVERS) community cohort and Severe Acute Respiratory Infection (SARI) hospital surveillance emerged as the most useful systems, achieving the highest scores in both training and short-term forecasting in community and hospital settings, respectively. The National Minimum Dataset of hospitalizations and mortality datasets demonstrated strong training potential but are limited in short-term forecasting due to timeliness constraints. Additionally, laboratory-based surveillance performs a useful role in bridging community and hospital datasets.

Conclusions

A set of key attributes is useful for assessing which influenza surveillance systems are best aligned with AI/ML training and short-term forecasting requirements. These attributes distinguished systems that are likely to be the most suitable for modeling future short-term disease scenarios for influenza at the community and hospital levels in New Zealand. Integrating these data sources could enhance influenza forecasts to improve public health responses and intervention planning.

背景:公共卫生监测系统需要监测流感活动并指导采取措施,以减轻其对发病率、死亡率和卫生保健系统的严重影响。越来越多的人期望监测数据将支持使用人工智能(AI)和机器学习(ML)对未来短期疾病情景的建模。本研究探讨了流感监测如何支持高收入国家社区和医院层面基于人工智能/机器学习的流感短期预测(Aotearoa/新西兰)。方法本研究采用两阶段方法。第一阶段包括对政府报告、官方网站和文献进行全面审查,以确定现有流感监测系统的特点。第二阶段评估系统的八个关键属性——及时性、敏感性、特异性、代表性、覆盖面、稳健性、完整性和历史数据——使用一个五级排名系统。属性选择是根据专家的知识、ML需求和已建立的框架进行的。计算训练和短期预测能力的加权分数,以确定与AI/ML要求的一致性。结果南半球流感和疫苗有效性研究与监测(SHIVERS)社区队列和严重急性呼吸道感染(SARI)医院监测成为最有用的系统,分别在社区和医院设置的培训和短期预测方面获得了最高分。住院和死亡率数据集的国家最低数据集显示出强大的培训潜力,但由于时效性限制,在短期预测方面受到限制。此外,基于实验室的监测在连接社区和医院数据集方面发挥了有用的作用。一组关键属性有助于评估哪些流感监测系统最符合人工智能/机器学习培训和短期预测要求。这些属性区分了可能最适合在新西兰社区和医院级别模拟未来短期流感疾病情景的系统。整合这些数据来源可以加强流感预测,以改进公共卫生反应和干预规划。
{"title":"A Framework for Evaluating the Use of Surveillance Systems for Short-Term Influenza Forecasting","authors":"Negin Maroufi,&nbsp;Lucy Telfar Barnard,&nbsp;Qiu Sue Huang,&nbsp;Gillian Dobbie,&nbsp;Nayyereh Aminisani,&nbsp;Steffen Albrecht,&nbsp;Nhung Nghiem,&nbsp;Michael G. Baker","doi":"10.1111/irv.70144","DOIUrl":"https://doi.org/10.1111/irv.70144","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Public health surveillance systems need to monitor influenza activity and guide measures to mitigate its high impact on morbidity, mortality and healthcare systems. There is an increasing expectation that surveillance data will support the modeling of future short-term disease scenarios using artificial intelligence (AI) and machine learning (ML). This study examines how influenza surveillance can support AI/ML-based short-term forecasting for influenza at the community and hospital levels in a high-income country setting (Aotearoa/New Zealand).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>This study used a two-phase approach. The first phase involved a comprehensive review of government reports, official websites, and literature to characterize existing influenza surveillance systems. The second phase evaluated systems against eight key attributes—timeliness, sensitivity, specificity, representativeness, coverage, robustness, completeness, and historical data—using a five-level ranking system. Attribute selection was informed by experts' knowledge, ML requirements, and established frameworks. Weighted scores for training and short-term forecasting capabilities were calculated to determine alignment with AI/ML requirements.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The Southern Hemisphere Influenza and Vaccine Effectiveness Research and Surveillance (SHIVERS) community cohort and Severe Acute Respiratory Infection (SARI) hospital surveillance emerged as the most useful systems, achieving the highest scores in both training and short-term forecasting in community and hospital settings, respectively. The National Minimum Dataset of hospitalizations and mortality datasets demonstrated strong training potential but are limited in short-term forecasting due to timeliness constraints. Additionally, laboratory-based surveillance performs a useful role in bridging community and hospital datasets.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>A set of key attributes is useful for assessing which influenza surveillance systems are best aligned with AI/ML training and short-term forecasting requirements. These attributes distinguished systems that are likely to be the most suitable for modeling future short-term disease scenarios for influenza at the community and hospital levels in New Zealand. Integrating these data sources could enhance influenza forecasts to improve public health responses and intervention planning.</p>\u0000 </section>\u0000 </div>","PeriodicalId":13544,"journal":{"name":"Influenza and Other Respiratory Viruses","volume":"19 8","pages":""},"PeriodicalIF":4.2,"publicationDate":"2025-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/irv.70144","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144725620","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Seasonal Incidence of Human Metapneumovirus in High-Risk Adults With Medically Attended Acute Respiratory Illness in a Rural US Community 美国农村社区急性呼吸道疾病高危成人中人偏肺病毒的季节性发病率
IF 4.3 4区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2025-07-17 DOI: 10.1111/irv.70119
Maria E. Sundaram, David L. McClure, Oluwakemi D. Alonge, Jennifer P. King, Jennifer K. Meece, Huong Q. Nguyen

Background

The burden of human metapneumovirus (hMPV) among community-dwelling high-risk adults is understudied. We calculate the cumulative incidence of outpatient hMPV in high-risk adults, over five consecutive winter respiratory virus seasons (2015–2016 through 2019–2020), and describe clinical characteristics of their illnesses.

Methods

We conducted a retrospective analysis of data and respiratory specimens from adults ≥ 18 years old originally participating in a test-negative study of influenza vaccine effectiveness. We included adults with ≥ 1 high-risk condition in 2015–2016 through 2019–2020 seasons. Residual respiratory specimens were retested for hMPV using a multiplex viral panel. We calculated seasonal incidence using Poisson regression and population weighting, with the sum of observed and extrapolated hMPV cases in the study cohort divided by the number of adults with high-risk conditions in the underlying source population.

Results

We tested 3601 respiratory samples; the mean (SD) age of individuals contributing samples was 53 (19) years. We identified 289 individuals (8.0%) with a respiratory sample positive for human metapneumovirus. The estimated seasonal incidence of outpatient hMPV-associated acute respiratory illness was 95.6 (95% CI: 80.5–113.4) cases per 10,000 high-risk adults. These values varied by season, with the highest incidence in 2015–2016 (276.8 cases per 10,000; 95% CI: 210.7–363.5) and lowest in 2016–17 (55.0 cases per 10,000; 95% CI: 31.2–97.0).

Conclusions

We identified substantial seasonal incidence of hMPV cases in community-dwelling high-risk adults in a Wisconsin population cohort.

背景目前对社区高危成人人偏肺病毒(hMPV)感染负担的研究尚不充分。我们计算了连续5个冬季呼吸道病毒季节(2015-2016年至2019-2020年)高危成人门诊hMPV的累积发病率,并描述了他们疾病的临床特征。方法我们对最初参与流感疫苗有效性试验阴性研究的≥18岁成人的数据和呼吸道标本进行回顾性分析。我们纳入了2015-2016年至2019-2020年期间有≥1种高危疾病的成年人。使用多重病毒面板重新检测残余呼吸道标本的hMPV。我们使用泊松回归和人群加权计算季节性发病率,将研究队列中观察到的和推断出的hMPV病例的总和除以潜在源人群中具有高危条件的成人人数。结果共检测呼吸道样本3601份;提供样本的个体的平均(SD)年龄为53(19)岁。我们发现289人(8.0%)呼吸道样本呈人偏肺病毒阳性。门诊hmpv相关急性呼吸道疾病的季节性发病率估计为每10,000名高危成人95.6例(95% CI: 80.5-113.4)。这些数值因季节而异,2015-2016年发病率最高(每万人276.8例;95% CI: 210.7-363.5), 2016 - 2017年最低(每万人55.0例;95% ci: 31.2-97.0)。结论:我们在威斯康辛州人群队列中发现了hMPV病例在社区高危成人中的季节性发生率。
{"title":"Seasonal Incidence of Human Metapneumovirus in High-Risk Adults With Medically Attended Acute Respiratory Illness in a Rural US Community","authors":"Maria E. Sundaram,&nbsp;David L. McClure,&nbsp;Oluwakemi D. Alonge,&nbsp;Jennifer P. King,&nbsp;Jennifer K. Meece,&nbsp;Huong Q. Nguyen","doi":"10.1111/irv.70119","DOIUrl":"https://doi.org/10.1111/irv.70119","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>The burden of human metapneumovirus (hMPV) among community-dwelling high-risk adults is understudied. We calculate the cumulative incidence of outpatient hMPV in high-risk adults, over five consecutive winter respiratory virus seasons (2015–2016 through 2019–2020), and describe clinical characteristics of their illnesses.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We conducted a retrospective analysis of data and respiratory specimens from adults ≥ 18 years old originally participating in a test-negative study of influenza vaccine effectiveness. We included adults with ≥ 1 high-risk condition in 2015–2016 through 2019–2020 seasons. Residual respiratory specimens were retested for hMPV using a multiplex viral panel. We calculated seasonal incidence using Poisson regression and population weighting, with the sum of observed and extrapolated hMPV cases in the study cohort divided by the number of adults with high-risk conditions in the underlying source population.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>We tested 3601 respiratory samples; the mean (SD) age of individuals contributing samples was 53 (19) years. We identified 289 individuals (8.0%) with a respiratory sample positive for human metapneumovirus. The estimated seasonal incidence of outpatient hMPV-associated acute respiratory illness was 95.6 (95% CI: 80.5–113.4) cases per 10,000 high-risk adults. These values varied by season, with the highest incidence in 2015–2016 (276.8 cases per 10,000; 95% CI: 210.7–363.5) and lowest in 2016–17 (55.0 cases per 10,000; 95% CI: 31.2–97.0).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>We identified substantial seasonal incidence of hMPV cases in community-dwelling high-risk adults in a Wisconsin population cohort.</p>\u0000 </section>\u0000 </div>","PeriodicalId":13544,"journal":{"name":"Influenza and Other Respiratory Viruses","volume":"19 7","pages":""},"PeriodicalIF":4.3,"publicationDate":"2025-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/irv.70119","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144647207","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transmission and Pathologic Findings of Divergent Human Seasonal H1N1pdm09 Influenza A Viruses Following Spillover Into Pigs in the United States 不同人类季节性h1n1 - pdm09甲型流感病毒在美国的传播和病理学发现
IF 4.3 4区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2025-07-17 DOI: 10.1111/irv.70128
Giovana Ciacci Zanella, Alexey Markin, Megan Neveau Thomas, Celeste A. Snyder, Carine K. Souza, Bailey Arruda, Tavis K. Anderson, Amy L. Baker

Background

The H1N1 pandemic (H1N1pdm09) lineage of influenza A viruses (IAV) emerged in North America in 2009. It spread rapidly due to efficient transmission and the limited immunity in humans, replacing the previous human seasonal H1. Human-to-swine transmission of H1N1pdm09 IAV has since contributed to genetic diversity in pigs. While most were not sustained, approximately 160 spillovers persisted in pigs in the United States for at least 1 year and reassorted with other endemic swine IAVs in most cases.

Methods

We sought to identify how transmission and reassortment with endemic IAV in swine impact virus traits and zoonotic risk in this study. We conducted a swine pathogenesis and transmission study using four swine H1N1pdm09 viruses derived from different human influenza seasons that had acquired different gene segment combinations after spillovers into swine. To assess antigenic evolution, we compared the selected swine H1N1pdm09 strains against each other and to five human seasonal H1 vaccine strains.

Results

Ongoing circulation and reassortment resulted in viruses with variable virulence, shedding, and transmission kinetics. The H1N1pdm09 viruses retained antigenic similarities with the human vaccine strain of the same season of incursion but showed increasing antigenic distances with human seasonal H1N1 vaccine strains from other seasons.

Conclusions

Human seasonal H1N1 viruses are capable of replicating and transmitting in swine, and there is potential for these human-to-swine spillovers to reassort with endemic swine IAV. Controlling IAV at the human-swine interface has the benefit of reducing IAV burden in swine and subsequent zoonotic risk.

甲型流感病毒(IAV)的H1N1大流行(H1N1pdm09)谱系于2009年在北美出现。由于人类的有效传播和有限的免疫力,它迅速传播,取代了以前的人类季节性H1。H1N1pdm09病毒的人-猪传播已导致猪的遗传多样性。虽然大多数没有持续,但在美国,大约有160例外溢在猪中持续了至少1年,并在大多数情况下与其他地方性猪病毒重新组合。方法在本研究中,我们试图确定猪流行性IAV的传播和重组如何影响病毒特性和人畜共患风险。我们利用从不同人类流感季节衍生的四种猪H1N1pdm09病毒进行了猪的发病机制和传播研究,这些病毒在外溢到猪体内后获得了不同的基因片段组合。为了评估抗原进化,我们将选定的猪H1N1pdm09毒株与其他毒株以及5种人类季节性H1疫苗毒株进行了比较。结果持续的循环和重组导致病毒具有不同的毒力、脱落和传播动力学。H1N1pdm09病毒与同一入侵季节的人H1N1疫苗株保持抗原相似性,但与其他季节的人H1N1季节性疫苗株的抗原距离增加。结论人季节性H1N1病毒具有在猪群中复制和传播的能力,这些人-猪外溢可能与地方性猪流感病毒重新组合。在人-猪交界面控制禽流感有利于减少猪的禽流感负担和随后的人畜共患风险。
{"title":"Transmission and Pathologic Findings of Divergent Human Seasonal H1N1pdm09 Influenza A Viruses Following Spillover Into Pigs in the United States","authors":"Giovana Ciacci Zanella,&nbsp;Alexey Markin,&nbsp;Megan Neveau Thomas,&nbsp;Celeste A. Snyder,&nbsp;Carine K. Souza,&nbsp;Bailey Arruda,&nbsp;Tavis K. Anderson,&nbsp;Amy L. Baker","doi":"10.1111/irv.70128","DOIUrl":"https://doi.org/10.1111/irv.70128","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>The H1N1 pandemic (H1N1pdm09) lineage of influenza A viruses (IAV) emerged in North America in 2009. It spread rapidly due to efficient transmission and the limited immunity in humans, replacing the previous human seasonal H1. Human-to-swine transmission of H1N1pdm09 IAV has since contributed to genetic diversity in pigs. While most were not sustained, approximately 160 spillovers persisted in pigs in the United States for at least 1 year and reassorted with other endemic swine IAVs in most cases.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We sought to identify how transmission and reassortment with endemic IAV in swine impact virus traits and zoonotic risk in this study. We conducted a swine pathogenesis and transmission study using four swine H1N1pdm09 viruses derived from different human influenza seasons that had acquired different gene segment combinations after spillovers into swine. To assess antigenic evolution, we compared the selected swine H1N1pdm09 strains against each other and to five human seasonal H1 vaccine strains.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Ongoing circulation and reassortment resulted in viruses with variable virulence, shedding, and transmission kinetics. The H1N1pdm09 viruses retained antigenic similarities with the human vaccine strain of the same season of incursion but showed increasing antigenic distances with human seasonal H1N1 vaccine strains from other seasons.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Human seasonal H1N1 viruses are capable of replicating and transmitting in swine, and there is potential for these human-to-swine spillovers to reassort with endemic swine IAV. Controlling IAV at the human-swine interface has the benefit of reducing IAV burden in swine and subsequent zoonotic risk.</p>\u0000 </section>\u0000 </div>","PeriodicalId":13544,"journal":{"name":"Influenza and Other Respiratory Viruses","volume":"19 7","pages":""},"PeriodicalIF":4.3,"publicationDate":"2025-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144647206","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Influenza Vaccine Effectiveness in Australia During 2017–2019 2017-2019年澳大利亚流感疫苗的有效性
IF 4.3 4区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2025-07-16 DOI: 10.1111/irv.70137
Tanya Diefenbach-Elstob, Monique B. Chilver, Violeta Spirkoska, Kylie S. Carville, Clyde Dapat, Mark Turra, Thomas Tran, Yi-Mo Deng, Heidi Peck, Ian G. Barr, Nigel Stocks, Sheena G. Sullivan

Background

Vaccine effectiveness (VE) estimates provide important post-marketing assessment of how well seasonal influenza vaccines prevent medically attended influenza disease. We present VE estimates for primary care in Australia for the 2017–2019 seasons.

Methods

The study used a test-negative design. Influenza VE was estimated from adjusted logistic regression models comparing the odds of vaccination among influenza-test-positive cases and test-negative non-cases. Estimates were made overall and separately by influenza type, subtype, lineage and clade and stratified by age group. Antigenic similarity of influenza viruses to vaccine strains was assessed using the haemagglutination inhibition assay, and phylogenetic analysis was performed on sequenced viruses.

Results

The study included 2879, 1973 and 3371 general practice patients with swabs collected during 2017, 2018 and 2019 respectively. Influenza A(H3N2) was predominant in 2017 and 2019, while influenza A(H1N1)pdm09 predominated in 2018. VE was estimated at 37% (95% CI 22, 48) for the 2017 season, 53% (95% CI 33, 67) for 2018 and 50% (95% CI 40, 58) for 2019. In general, estimates were higher against A(H1N1)pdm09 and influenza B viruses and lower against A(H3N2) viruses. Across the three seasons, antigenic data identified a greater proportion of A(H1N1)pdm09 and influenza B viruses than A(H3N2) viruses as antigenically similar to the cell-propagated reference viruses. VE estimates by clade generally indicated higher VE among viruses in the same clade as the vaccine viruses.

Conclusions

Influenza VE varied across influenza seasons and by influenza type/subtype. Given the ongoing evolution of circulating influenza viruses, vaccine improvements are needed, especially for influenza A(H3N2).

疫苗有效性(VE)评估提供了重要的上市后评估,以评估季节性流感疫苗预防医学上的流感疾病的效果。我们给出了2017-2019年澳大利亚初级保健的VE估计。方法采用阴性试验设计。通过调整后的logistic回归模型,比较流感检测阳性病例和检测阴性非病例的疫苗接种几率,估计流感VE。根据流感类型、亚型、谱系和分支进行总体和单独的估计,并按年龄组分层。利用血凝抑制试验评估流感病毒与疫苗株的抗原相似性,并对测序病毒进行系统发育分析。结果本研究纳入2017年、2018年和2019年分别采集的2879例、1973例和3371例全科患者拭子。2017年和2019年以甲型流感(H3N2)为主,2018年以甲型H1N1流感(pdm09)为主。2017年的VE估计为37% (95% CI为22,48),2018年为53% (95% CI为33,67),2019年为50% (95% CI为40,58)。一般来说,甲型H1N1 pdm09和乙型流感病毒的估计值较高,甲型H3N2病毒的估计值较低。在三个季节中,抗原数据发现甲型H1N1 pdm09和乙型流感病毒比甲型H3N2病毒在抗原性上与细胞繁殖的参考病毒相似。按进化支估计的VE通常表明,与疫苗病毒在同一进化支中的病毒具有更高的VE。结论流感VE在流感季节和流感类型/亚型之间存在差异。鉴于流行流感病毒的不断演变,需要改进疫苗,特别是针对甲型流感(H3N2)。
{"title":"Influenza Vaccine Effectiveness in Australia During 2017–2019","authors":"Tanya Diefenbach-Elstob,&nbsp;Monique B. Chilver,&nbsp;Violeta Spirkoska,&nbsp;Kylie S. Carville,&nbsp;Clyde Dapat,&nbsp;Mark Turra,&nbsp;Thomas Tran,&nbsp;Yi-Mo Deng,&nbsp;Heidi Peck,&nbsp;Ian G. Barr,&nbsp;Nigel Stocks,&nbsp;Sheena G. Sullivan","doi":"10.1111/irv.70137","DOIUrl":"https://doi.org/10.1111/irv.70137","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Vaccine effectiveness (VE) estimates provide important post-marketing assessment of how well seasonal influenza vaccines prevent medically attended influenza disease. We present VE estimates for primary care in Australia for the 2017–2019 seasons.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>The study used a test-negative design. Influenza VE was estimated from adjusted logistic regression models comparing the odds of vaccination among influenza-test-positive cases and test-negative non-cases. Estimates were made overall and separately by influenza type, subtype, lineage and clade and stratified by age group. Antigenic similarity of influenza viruses to vaccine strains was assessed using the haemagglutination inhibition assay, and phylogenetic analysis was performed on sequenced viruses.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The study included 2879, 1973 and 3371 general practice patients with swabs collected during 2017, 2018 and 2019 respectively. Influenza A(H3N2) was predominant in 2017 and 2019, while influenza A(H1N1)pdm09 predominated in 2018. VE was estimated at 37% (95% CI 22, 48) for the 2017 season, 53% (95% CI 33, 67) for 2018 and 50% (95% CI 40, 58) for 2019. In general, estimates were higher against A(H1N1)pdm09 and influenza B viruses and lower against A(H3N2) viruses. Across the three seasons, antigenic data identified a greater proportion of A(H1N1)pdm09 and influenza B viruses than A(H3N2) viruses as antigenically similar to the cell-propagated reference viruses. VE estimates by clade generally indicated higher VE among viruses in the same clade as the vaccine viruses.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Influenza VE varied across influenza seasons and by influenza type/subtype. Given the ongoing evolution of circulating influenza viruses, vaccine improvements are needed, especially for influenza A(H3N2).</p>\u0000 </section>\u0000 </div>","PeriodicalId":13544,"journal":{"name":"Influenza and Other Respiratory Viruses","volume":"19 7","pages":""},"PeriodicalIF":4.3,"publicationDate":"2025-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/irv.70137","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144646796","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of K-12 School District Nonpharmaceutical Interventions on Community-Level Prevalence of Acute Respiratory Infection During the COVID-19 Pandemic K-12学区非药物干预措施对COVID-19大流行期间社区急性呼吸道感染患病率的影响
IF 4.3 4区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2025-07-13 DOI: 10.1111/irv.70139
C. He, M. D. Goss, D. Norton, G. Chen, A. Uzicanin, J. L. Temte

Background

Responding to the COVID-19 pandemic, kindergarten through 12th grade schools implemented nonpharmaceutical interventions (NPIs). The effects of school-based NPIs on broader community levels of acute respiratory infection (ARI) have not been defined. We utilized an existing longitudinal cohort of households reporting weekly ARI cases to evaluate the effects of evolving school districtwide NPIs on ARI activity at eight transition points from December 2019 through October 2022.

Methods

Household ARI data were reported through the GReat Oregon Child Absenteeism due to Respiratory Disease Study (ORCHARDS) Vaccine Effectiveness Study—a prospective cohort study based in the Oregon School District (OSD) (GROVES). Participating GROVES families completed weekly online surveys with respiratory illness updates. Mixed effects logistic regression was used to examine the association between eight school-related transition events during the COVID-19 pandemic and changes in the trajectory of ARI risk for GROVES family members, while accounting for family clusters. Transition events were assessed using a ±4-week window of community data.

Results

Opening schools with maximal NPIs (mandated masking and physical distancing, with hybrid education) was not associated with increased community ARI activity. The four transition events associated with significant ARI risk trajectory increases included summer breaks (June 2020, p = 0.001; June 2021, p = 0.002), and the start of school with mandatory masking only (September 2021, p < 0.001) or without NPIs (September 2022, p < 0.001).

Conclusions

School-based NPI implementation was associated with reduced risks for community ARI activity. Enhanced surveillance platforms such as the weekly online surveys used in this study are valuable tools for better understanding and monitoring SARS-CoV-2 and respiratory virus transmission in schools and surrounding communities.

为应对COVID-19大流行,幼儿园到12年级的学校实施了非药物干预措施(npi)。以学校为基础的npi对更广泛的社区急性呼吸道感染(ARI)水平的影响尚未确定。我们利用现有的家庭纵向队列,每周报告ARI病例,以评估2019年12月至2022年10月八个过渡点学区范围内不断变化的npi对ARI活动的影响。方法通过俄勒冈州呼吸系统疾病儿童缺勤研究(ORCHARDS)疫苗有效性研究(一项基于俄勒冈学区(GROVES)的前瞻性队列研究)报告家庭ARI数据。参与的格罗夫斯家庭完成了每周的呼吸道疾病更新在线调查。采用混合效应逻辑回归分析了COVID-19大流行期间8个与学校相关的过渡事件与GROVES家庭成员急性呼吸道感染风险轨迹变化之间的关联,同时考虑了家庭聚集性。使用±4周的社区数据窗口来评估过渡事件。结果开设npi最高的学校(强制遮蔽和保持身体距离,混合教育)与社区ARI活动增加无关。与ARI风险轨迹显著增加相关的四个过渡事件包括暑假(2020年6月,p = 0.001;2021年6月,p = 0.002),以及只有强制性遮盖(2021年9月,p < 0.001)或没有npi(2022年9月,p < 0.001)的学校开学。结论:基于学校的NPI实施与社区ARI活动风险降低相关。加强监测平台,如本研究中使用的每周在线调查,是更好地了解和监测学校和周围社区中SARS-CoV-2和呼吸道病毒传播的宝贵工具。
{"title":"Effects of K-12 School District Nonpharmaceutical Interventions on Community-Level Prevalence of Acute Respiratory Infection During the COVID-19 Pandemic","authors":"C. He,&nbsp;M. D. Goss,&nbsp;D. Norton,&nbsp;G. Chen,&nbsp;A. Uzicanin,&nbsp;J. L. Temte","doi":"10.1111/irv.70139","DOIUrl":"https://doi.org/10.1111/irv.70139","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Responding to the COVID-19 pandemic, kindergarten through 12th grade schools implemented nonpharmaceutical interventions (NPIs). The effects of school-based NPIs on broader community levels of acute respiratory infection (ARI) have not been defined. We utilized an existing longitudinal cohort of households reporting weekly ARI cases to evaluate the effects of evolving school districtwide NPIs on ARI activity at eight transition points from December 2019 through October 2022.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Household ARI data were reported through the GReat Oregon Child Absenteeism due to Respiratory Disease Study (ORCHARDS) Vaccine Effectiveness Study—a prospective cohort study based in the Oregon School District (OSD) (GROVES). Participating GROVES families completed weekly online surveys with respiratory illness updates. Mixed effects logistic regression was used to examine the association between eight school-related transition events during the COVID-19 pandemic and changes in the trajectory of ARI risk for GROVES family members, while accounting for family clusters. Transition events were assessed using a ±4-week window of community data.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Opening schools with maximal NPIs (mandated masking and physical distancing, with hybrid education) was not associated with increased community ARI activity. The four transition events associated with significant ARI risk trajectory increases included summer breaks (June 2020, <i>p</i> = 0.001; June 2021, <i>p</i> = 0.002), and the start of school with mandatory masking only (September 2021, <i>p</i> &lt; 0.001) or without NPIs (September 2022, <i>p</i> &lt; 0.001).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>School-based NPI implementation was associated with reduced risks for community ARI activity. Enhanced surveillance platforms such as the weekly online surveys used in this study are valuable tools for better understanding and monitoring SARS-CoV-2 and respiratory virus transmission in schools and surrounding communities.</p>\u0000 </section>\u0000 </div>","PeriodicalId":13544,"journal":{"name":"Influenza and Other Respiratory Viruses","volume":"19 7","pages":""},"PeriodicalIF":4.3,"publicationDate":"2025-07-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/irv.70139","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144615266","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Influenza and Other Respiratory Viruses
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1